Cancer.
Conditions
Interventions
Intervention group: Patients treating using Grid as an additional session. Control group: The control group is used for historical control and the results of the treatment will be compared to those wh
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Palliative bulky tumors, radio-resistant tumors such as sarcoma, etc., which do not respond well to conventional radiotherapy.
Exclusion criteria
Exclusion criteria: If a large and radiation-resistant tumor is located close to a sensitive normal tissue , such as the optic nerve and the spinal cord, it is excluded. In this study, there is a one-week interval between Grid therapy and conventional radiotherapy. If this duration is not feasible for the patient due to his/her bad performance, the patient will be excluded from this study and just conventional radiotherapy will be considered for the patient.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Tumor size. Timepoint: each three month. Method of measurement: Imagging. | — |
Secondary
| Measure | Time frame |
|---|---|
| Tumor response. Timepoint: ?? ??? ?????. Method of measurement: imaging. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSomayeh Gholami
Tehran University of Medical Sciences
Outcome results
None listed